
Wegovy®
Wegovy®, on prescription after an online consultation with a licensed doctor.
Plans
| Plan | Billed | Price |
|---|---|---|
| 0.25 mg · every month | Every 28 days, until cancelled | ₱12,990.00 ₱14,990 from 1.7 mg VAT inclusive |
At a glance
- The FDA-approved Wegovy® from Novo Nordisk
- GLP-1 approved specifically for weight loss
- Prescribed and guided by licensed Filipino doctors
- How it is taken
- Injected under the skin, once a week
- Where to inject
- Stomach area
- Thigh
- Upper arm
- Storing it
- Keep it in the fridge at 2–8°C until you start using it. Do not freeze it — a pen or vial that has frozen must be thrown away. Keep away from light and out of reach of children. Once you have started a pen or vial, check its label for how long it may stay at room temperature, and do not use it beyond that. Do not use it if the liquid is cloudy, coloured or has particles in it.
What it is
Wegovy® is an FDA-approved prescription medication that contains semaglutide. It is designed to help regulate appetite, reduce food intake, and support sustained weight loss when used alongside healthy lifestyle habits. Wegovy® works by mimicking GLP-1, a hormone your body naturally produces to signal fullness and slow gastric emptying. This action helps reduce hunger, limit cravings, and support steady, sustainable weight loss under medical supervision. Wegovy® is available by prescription only and should be used as directed by a licensed healthcare provider.
How to take it
No clinic visits. No pharmacy queues. No explaining yourself at a counter. Your Wegovy® pen arrives with everything you need and a step-by-step guide . You inject once weekly with a very small needle, and most people say they barely feel it. You start low, then you and your &you doctor adjust gradually, at your body's pace, until you reach the dose that's right for you. The whole thing happens from your phone.
What to expect
Imagine a few weeks from now: the cravings that used to run your day have faded into the background. Many patients notice their appetite quieting within the first 2 to 4 weeks. In clinical trials of semaglutide 2.4mg for weight management, people lost up to around 15% of their body weight on average over about 68 weeks alongside diet and exercise. Meaningful weight change typically follows over the months that follow, and because you build up gradually, it's progress your body can actually hold onto. Results vary from person to person, and your doctor tracks yours and adjusts as you go.
When to stop and seek help
Some people don't feel anything, others feel it briefly: nausea, diarrhea, constipation, or stomach discomfort. These are usually mild to moderate and tend to fade as your body adjusts, which is exactly why your dose goes up slowly instead of all at once. And you're never left to figure it out alone. If anything feels off, your &you doctor is a message away, consultations included.
Storing it
- Keep it in the fridge at 2–8°C until you start using it. Do not freeze it — a pen or vial that has frozen must be thrown away. - Keep away from light and out of reach of children. - Once you have started a pen or vial, check its label for how long it may stay at room temperature, and do not use it beyond that. - Do not use it if the liquid is cloudy, coloured or has particles in it.
The small print
A mandatory doctor consultation is required before starting treatment. During the consultation, your &you doctor will provide training and detailed guidance to ensure you can safely self-administer your dose. Our weight loss treatments are intended for patients with: • A BMI of 30 kg/m² or higher, or • A BMI of 27 kg/m² or higher with at least one weight-related condition Patients with type 1 diabetes are not eligible for treatment. You may use our BMI calculator or speak with our doctors to confirm eligibility. Please note that the pen may not appear full, but it contains the exact amount prescribed specifically for you by our doctors. Wegovy® is an FDA-approved prescription medication trusted by healthcare providers to support chronic weight management. It contains semaglutide, a GLP-1 receptor agonist that helps regulate appetite and food intake when used alongside a healthy diet and lifestyle. Wegovy® is FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition.